Chengda Biotechnology
Latest round
- Series A
Last raised
- May 2014
Total raised
- Undisclosed
Investors
- 3
About Chengda Biotechnology
Established in 2002 and based in Liaoning, China, Chengda Biotechnology operates as a biotechnology company that focuses on rabies vaccine production. The company provides vaccine production. The product of the company includes human rabies vaccine, veterinary rabies vaccine and human JE inactivated vaccine.
Who invested in Chengda Biotechnology
3 investors across 2 rounds
See all investors in Chengda Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Chengda Biotechnology
Who invested in Chengda Biotechnology?
Chengda Biotechnology has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chengda Biotechnology raised?
Chengda Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Chengda Biotechnology last raise money?
Chengda Biotechnology's most recent round on record is a Series A, in May 2014.
What does Chengda Biotechnology do?
Established in 2002 and based in Liaoning, China, Chengda Biotechnology operates as a biotechnology company that focuses on rabies vaccine production.
Where is Chengda Biotechnology headquartered?
Chengda Biotechnology is headquartered in Shenyang, China.
Which VCs invest in companies like Chengda Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Chengda Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Chengda Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.